Vaping and vaping-associated lung injury: A review

Cover Page

Cite item

Full Text

Abstract

Vaping, i.e. the use of electronic nicotine/other substances delivery systems, increases a risk of vaping-associated lung injury. The review describes clinical manifestation, methods of diagnosis and diagnostic criteria, treatment of patients with this disease as well as risk stratification of vapers and approaches to their management based on Worchester classification and clinical guidance. The pathogenetic mechanisms of vaping-associated lung injury have been analyzed.

About the authors

Valery I. Podzolkov

Sechenov First Moscow State Medical University (Sechenov University)

Email: vetluzhskaya_m_v@staff.sechenov.ru
ORCID iD: 0000-0002-0758-5609

д-р мед. наук, проф., зав. каф. факультетской терапии №2

Russian Federation, Moscow

Maria V. Vetluzhskaya

Sechenov First Moscow State Medical University (Sechenov University)

Author for correspondence.
Email: vetluzhskaya_m_v@staff.sechenov.ru
ORCID iD: 0000-0001-9733-4813

канд. мед. наук, доц. каф. факультетской терапии №2

Russian Federation, Moscow

Antonina A. Abramova

Sechenov First Moscow State Medical University (Sechenov University)

Email: vetluzhskaya_m_v@staff.sechenov.ru
ORCID iD: 0000-0002-3311-6072

канд. мед. наук, доц. каф. факультетской терапии №2

Russian Federation, Moscow

Tatiana I. Ishina

Sechenov First Moscow State Medical University (Sechenov University)

Email: vetluzhskaya_m_v@staff.sechenov.ru
ORCID iD: 0000-0001-7720-0770

канд. мед. наук, доц. каф. факультетской терапии №2

Russian Federation, Moscow

Karina I. Garifullina

Sechenov First Moscow State Medical University (Sechenov University)

Email: vetluzhskaya_m_v@staff.sechenov.ru
ORCID iD: 0000-0001-6229-1497

ординатор

Russian Federation, Moscow

References

  1. Market Research Blog. MacGuill Sh. Growth in vapour products. 2017 Nov 01. Available at: https://blog.euromonitor.com/growth-vapour-products/ Accessed: 12.05.2022.
  2. U.S. Department of Health and Human Services. E-Cigarette Use Among Youth and Young Adults. A Report of the Surgeon General. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2016. Available at: https://www.cdc.gov/tobacco/data_statistics/sgr/e-cigarettes/pdfs/2016_sgr_entire_report_508.pdf. Accessed: 27.07.2018.
  3. Miech R, Johnston L, O’Malley PM, et al. Trends in Adolescent Vaping, 2017–2019 October 10, 2019. N Engl J Med. 2019;381:1490-1. doi: 10.1056/NEJMc1910739
  4. Centres for Disease Control and Prevention. Quick facts on the risks of e-cigarettes for kids, teens, and young adults. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/Quick-Facts-on-the-Risks-of-E-cigarettes-for-Kids-Teens-and-Young-Adults.html. Accessed: 12.05.2022.
  5. Kasza KA, Ambrose BK, Conway KP, et al. Tobacco-product use by adults and youths in the United States in 2013 and 2014. N Engl J Med. 2017;376(4):342-53. doi: 10.1056/NEJMsa1607538
  6. Miech R, Johnston L, O'Malley PM, et al. Adolescent vaping and nicotine use in 2017–2018 – U.S. National Estimates. N Engl J Med. 2019;380(2):192-3. doi: 10.1056/NEJMc1814130
  7. Jamal A, Gentzke A, Hu SS, et al. Tobacco use among middle and high school students – United States, 2011–2016. MMWR Morb Mortal Wkly Rep. 2017;66(23):597-603. doi: 10.15585/mmwr.mm6623a1
  8. Huang J, Kornfield R, Emery SL. 100 Million views of electronic cigarette YouTube videos and counting: quantification, content evaluation, and engagement levels of videos. J Med Internet Res. 2016;18(3):e67. doi: 10.2196/jmir.4265
  9. Boccio CM, Jackson DB. Adolescent nicotine and marijuana vaping activity and the use of other illicit substances. Drug Alcohol Depend. 2021;219:108469. doi: 10.1016/j.drugalcdep.2020.108469
  10. Доклад ВОЗ. Электронные системы доставки никотина. Конференция Сторон Рамочной конвенции ВОЗ по борьбе против табака, шестая сессия; 1 сентября 2014 г., Москва, Российская Федерация. Режим доступа: https://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10Rev1-ru.pdf?ua=1&ua=1. Ссылка активна на 05.12.2022 [WHO report. Electronic nicotine delivery systems. Conference of the Parties to the WHO Framework Convention on Tobacco Control, sixth session; September 1, 2014, Moscow, Russian Federation. Available at: https://apps.who.int/gb/fctc/PDF/cop6/FCTC_COP6_10Rev1-ru.pdf?ua=1&ua=1. Accessed: 12.05.2022 (in Russian)].
  11. Sohal SS, Eapen MS, Naidu VGM, Sharma P. IQOS exposure impairs human airway cell homeostasis: direct comparison with traditional cigarette and e-cigarette. ERJ Open Res. 2019;5(1):00159-2018. doi: 10.1183/23120541.00159-2018
  12. Centres for Disease control and Prevention. Outbreak of lung injury associated with the use e-cigarette, or vaping, products [updated 2020 Feb 25]. Available at: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html. Accessed: 12.05.2022.
  13. Layden JE, Ghinai I, Pray I, et al. Pulmonary illness related to e-cigarette use in Illinois and Wisconsin – final report. N Engl J Med. 2020;382(10):903-16. doi: 10.1056/NEJMoa1911614
  14. Crotty Alexander LE, Ware LB, Calfee CS, et al. E-cigarette or vaping product use-associated lung injury: developing a research agenda. An NIH Workshop Report. Am J Respir Crit Care Med. 2020;202(6):795-802. doi: 10.1164/rccm.201912-2332WS
  15. Hage R, Fretz V, Schuurmans MM. Electronic cigarettes and vaping associated pulmonary illness (VAPI): A narrative review. Pulmonology. 2020;5(26):291-303. doi: 10.1016/j.pulmoe.2020.02.009
  16. Kligerman S, Raptis C, Larsen B, et al. Radiologic, pathologic, clinical, and physiologic findings of electronic cigarette or vaping product use-associated lung injury (EVALI): evolving knowledge and remaining questions. Radiology. 2020;294(3):491-505. doi: 10.1148/radiol.2020192585
  17. Panse PM, Feller FF, Butt YM, et al. Radiologic and pathologic correlation in EVALI. AJR Am J Roentgenol. 2020;215(5):1057-64. doi: 10.2214/AJR.20.22836
  18. Butt YM, Smith ML, Tazelaar HD, et al. Pathology of vaping-associated lung injury. N Engl J Med. 2019;381(18):1780-1. doi: 10.1056/NEJMc1913069
  19. Maddock SD, Cirulis MM, Callahan SJ, et al. Pulmonary lipid-laden macrophages and vaping. N Engl J Med. 2019;381(15):1488-9. doi: 10.1056/NEJMc1912038
  20. Guerrini V, Panettieri RA Jr., Gennaro ML. Lipid-laden macrophages as biomarkers of vaping-associated lung injury. Lancet Respir Med. 2020;8(2):e6. doi: 10.1016/S2213-2600(19)30476-X
  21. Cecchini MJ, Mukhopadhyay S, Arrossi AV, et al. E-cigarette or vaping product use-associated lung injury: a review for pathologists. Arch Pathol Lab Med. 2020;144(12):1490-500. doi: 10.5858/arpa.2020-0024-RA
  22. Blount BC, Karwowski MP, Shields PG, et al. Vitamin E acetate in bronchoalveolar-lavage fluid associated with EVALI. N Engl J Med. 2020;382(8):697-705. doi: 10.1056/NEJMoa1916433
  23. Bhat TA, Kalathil SG, Bogner PN, et al. An animal model of inhaled vitamin E acetate and EVALI-like lung injury. N Engl J Med. 2020;382(12):1175-7. doi: 10.1056/NEJMc2000231
  24. Alexander LEC, Bellinghausen AL, Eakin MN. What are the mechanisms underlying vaping-induced lung injury? J Clin Invest. 2020;130(6):2754-6. doi: 10.1172/JCI138644
  25. Wu D, O'Shea DF. Potential for release of pulmonary toxic ketene from vaping pyrolysis of vitamin E acetate. Proc Natl Acad Sci U S A. 2020;117(12):6349-55. doi: 10.1073/pnas.1920925117
  26. Hardison LS Jr., Wright E, Pizon AF. Phosgene exposure: a case of accidental industrial exposure. J Med Toxicol. 2014;10(1):51-6. doi: 10.1007/s13181-013-0319-6
  27. Geiss O, Bianchi I, Barahona F, Barrero-Moreno J. Characterisation of mainstream and passive vapours emitted by selected electronic cigarettes. Int J Hyg Environ Health. 2015;218(1):169-80. doi: 10.1016/j.ijheh.2014.10.001
  28. Goel R, Durand E, Trushin N, et al. Highly reactive free radicals in electronic cigarette aerosols. Chem Res Toxicol. 2015;28(9):1675-7. doi: 10.1021/acs.chemrestox.5b00220
  29. Krishnasamy VP, Hallowell BD, Ko JY, et al. Update: characteristics of a nationwide outbreak of e-cigarette, or vaping, product ase-Associated lung injury – United States, August 2019 – January 2020. MMWR Morb Mortal Wkly Rep. 2020;69(3):90-4. doi: 10.15585/mmwr.mm6903e2
  30. Jatlaoui TC, Wiltz JL, Kabbani S, et al. Update: interim guidance for health care providers for managing patients with suspected e-cigarette, or vaping, product use-associated lung injury – United States, November 2019. MMWR Morb Mortal Wkly Rep. 2019;68(46):1081-6. doi: 10.15585/mmwr.mm6846e2
  31. Lilly CM, Khan S, Waksmundzki-Silva K, Irwin RS. Vaping-associated respiratory distress syndrome: case classification and clinical guidance. Crit Care Explor. 2020;2(2):e0081. doi: 10.1097/CCE.0000000000000081

Supplementary files

Supplementary Files
Action
1. JATS XML
Download
2. Fig. 1. Symptom- and oximetry-based risk stratification of vapers [31].

Download (12KB)
Indexing metadata
3. Fig. 2. Management of patients from groups 2 and 3 by Worcester Vaping Clinical Classification System based on oximetry and chest X-ray [31].

Download (38KB)
Indexing metadata

Copyright (c) 2023 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies